G. De Placido

No ORCID on file · 12 papers in corpus
case-report 2023
·doi:10.33140/jgrm.07.01.05

Umbilical endometriosis which was first described by Villar in 1886 is a rare clinical entity with a frequency of only 0.5-1%. The overall prevalence rate of endometriosis among women in their reproductive age is put at 5-10%. This is a des…

case-report 2006
Journal of Endocrinological Investigation ·doi:10.1007/BF03344095

An adult Caucasian female developed a previously unreported association of pelvic endometriosis (PE) with the triad of alopecia universalis (AU), autoimmune thyroiditis (AT) and multiple sclerosis (MS). Molecular human leukocyte antigen (HL…

other 2002
Journal of assisted reproduction and genetics ·doi:10.1023/a:1014054421789

PURPOSE: To test the effects of type of embryo transfer catheter, transfer difficulty, and observations after the transfer procedure on pregnancy and implantation rates in an IVF programme. METHODS: Patients were prepared for IVF using sta…

observational 2001
Human Reproduction ·doi:10.1093/humrep/16.6.1251

This study was designed to measure leptin concentrations in the peritoneal fluid (PF) of women with different aspects of pelvic endometriosis. Among 36 consecutive women undergoing laparoscopy, nine were diagnosed as having minimal-mild end…

rct 2000
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jcem.85.7.6703

Pelvic endometriosis is an immune-related chronic inflammatory disease, characterized by ectopic implants of endometrium in the peritoneal cavity and associated with increased secretion of proinflammatory cytokines and neoangiogenesis. Lept…

observational 1998
Human Reproduction ·doi:10.1093/humrep/13.11.3206

Serum concentrations of soluble human leukocyte class I antigens (sHLA-I) and of the intercellular adhesion molecule-1 (sICAM-1) are increased in the early inflammatory stages of several immune-related diseases. These soluble molecules also…

review 1996
Acta Europaea fertilitatis
nonrandomized-trial 1995
Clinical and experimental obstetrics & gynecology

UNLABELLED: STUDY-PLAN: an open study aimed at evaluating the results of a short term therapy (3 months) with Goserelin depot as a medical treatment of premenopausal dysfunctional uterine bleeding. PATIENTS: 60 premenopausal women (aged 36…

review 1992
Acta Europaea fertilitatis

Uterine bleeding may be caused either by benign organic pathology as well as different dysfunctional conditions. Medical treatment with progestins, danazol or GnRH analogues is usually used as the first choice therapy. Where the symptoms pe…

nonrandomized-trial 1992
Acta Europaea fertilitatis

Many experimental and clinical findings indicate a disimmune pathogenesis of infertility associated with endometriosis. The most important modifications of cell-mediated immunity in endometriosis concern macrophage activity, increased both …

nonrandomized-trial 1991
Minerva ginecologica

Perimenopausal abnormal bleeding is one of the most common gynecological problems. We have assessed the effectiveness of danazol 200 mg daily for 3 months in 42 patients with perimenopausal abnormal bleeding without any previous treatment a…

other 1991
Annals of the New York Academy of Sciences ·doi:10.1111/j.1749-6632.1991.tb37872.x